atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit – Psychedelic Alpha
NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of